TelyRx Holdings Inc. faces a significant setback as its stock drops over 9% in a single trading session.
In a turbulent trading day, TelyRx Holdings Inc. (TELY.TO) saw its stock price decline by 9.28%, closing at CA$2.15. This sharp drop raises concerns among investors about the company's current standing and future prospects.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
+10.20%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 122.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+122.2% Upside
Current Price
C$2.70
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.6%
Annualized
90-Day Vol
97.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.54 | C$1.79 – C$3.62 |
| 60 trading days | C$2.40 | C$1.45 – C$3.95 |
| 90 trading days | C$2.26 | C$1.22 – C$4.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should remain cautious as TelyRx's recent performance reflects ongoing volatility, and the lack of news may indicate underlying issues.
TelyRx Holdings Inc. Declines 9.28% in One Day
With a market cap of CA$62.99 million, TelyRx's stock price movement reflects heightened market sensitivity and investor uncertainty.
Bull case
Despite today’s drop, TelyRx has shown strong revenue growth in recent quarters. If management can seize market opportunities, there’s potential for recovery.
Bear case
The significant one-day decline raises concerns about investor confidence, especially since there hasn’t been any recent positive news to support the stock's valuation.
Market Reaction
The market's reaction to TelyRx's stock drop indicates a lack of confidence among investors. The 9.28% decline suggests that traders are wary, possibly due to the absence of recent positive developments or news from the company. With a market cap of CA$62.99 million, the stock's volatility may be more pronounced, leading to sharp movements in response to market sentiment.
Looking Ahead
As TelyRx continues to navigate its position in the market, investors should keep an eye on upcoming earnings reports and any strategic announcements. The company's recent revenue growth, as seen in its financial results, could provide a basis for recovery if they can maintain momentum. However, today's performance serves as a reminder of the risks involved in investing in smaller-cap stocks like TelyRx Holdings Inc.
Advertisement
